Elanco Animal Health Incorporated
General ticker "ELAN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $7.0B (TTM average)
Elanco Animal Health Incorporated follows the US Stock Market performance with the rate: 69.1%.
Estimated limits based on current volatility of 1.9%: low 22.03$, high 22.89$
Factors to consider:
- Total employees count: 9450 (-3.6%) as of 2024
- US accounted for 45.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on key products, Acquisition/divestiture risks, Restructuring risks, Supply chain disruptions, Liquidity and credit risks
- Current price 55.4% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.83$, 14.15$]
- 2025-12-31 to 2026-12-31 estimated range: [6.40$, 11.88$]
Financial Metrics affecting the ELAN estimates:
- Positive: with PPE of 13.1 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 5.65
- Negative: negative Industry operating cash flow (median)
- Positive: 6.82 < Operating cash flow per share per price, % of 9.21
- Negative: Return on assets ratio (scaled to [-100,100]) of 2.61 <= 6.04
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
Short-term ELAN quotes
Long-term ELAN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $4,411.00MM | $4,417.00MM | $4,439.00MM |
| Operating Expenses | $4,027.00MM | $4,091.00MM | $4,188.00MM |
| Operating Income | $384.00MM | $326.00MM | $251.00MM |
| Non-Operating Income | $-456.00MM | $-1,521.00MM | $237.00MM |
| Interest Expense | $256.00MM | $277.00MM | $339.00MM |
| R&D Expense | $321.00MM | $327.00MM | $344.00MM |
| Income(Loss) | $-72.00MM | $-1,195.00MM | $488.00MM |
| Taxes | $6.00MM | $36.00MM | $150.00MM |
| Profit(Loss)* | $-78.00MM | $-1,231.00MM | $338.00MM |
| Stockholders Equity | $7,289.00MM | $6,223.00MM | $6,096.00MM |
| Inventory | $1,538.00MM | $1,735.00MM | $1,574.00MM |
| Assets | $15,491.00MM | $14,362.00MM | $12,614.00MM |
| Operating Cash Flow | $452.00MM | $271.00MM | $541.00MM |
| Capital expenditure | $184.00MM | $154.00MM | $147.00MM |
| Investing Cash Flow | $-179.00MM | $-169.00MM | $1,158.00MM |
| Financing Cash Flow | $-549.00MM | $-83.00MM | $-1,492.00MM |
| Earnings Per Share** | $-0.16 | $-2.50 | $0.68 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.